Dr Voss Gibson•
RSV, Flu and COVID at the Same Time? Australia’s Triple Respiratory Threat Explained
The triple respiratory threat in Australia has been significant throughout 2025, with influenza, COVID-19, and respiratory syncytial virus (RSV) circulating simultaneously. National notifications show over 282,000 laboratory-confirmed flu cases, approximately 240,000 COVID-19 cases, and 139,000 RSV detections by late 2025—many times higher than 2024 levels. This overlap, sometimes called a “tripledemic”, increases risks for vulnerable groups and strains healthcare.
Vaccination and early intervention remain key. If you or your family have respiratory symptoms, telehealth consultations allow prompt advice from AHPRA-registered doctors without leaving home.
Understanding the Triple Respiratory Threat in Australia
These three viruses peak in winter and can co-infect, complicating illness.
Recent Trends and Case Numbers
In 2025, influenza cases reached 282,443 nationally by December, with a peak of over 150,000 in June–July. COVID-19 notifications exceeded 240,000, while RSV detections hit 139,000—50% higher than 2024.
Early 2026 shows ongoing circulation, particularly flu and COVID.
| :Virus | :2024 Cases (approx.) | :2025 Cases (approx.) |
| :Influenza | :77,000 | :282,000 |
| :COVID-19 | :Lower wave | :240,000 |
| :RSV | :92,000 | :139,000 |
(Source: National Notifiable Diseases Surveillance System and Australian Respiratory Surveillance Reports)
Why These Viruses Are Surging Together
Lower vaccination uptake (only 29% of adults received flu vaccine in 2025), reduced population immunity post-COVID restrictions, and seasonal winter overlap drive the surge. Children under 5 and older adults face highest hospitalisation risks.
Co-infection is possible, though rare. Semantically related: tripledemic, co-circulation, respiratory viruses.
What Are RSV, Flu, and COVID?
Each virus affects the respiratory tract but differs in severity and target groups.
Respiratory Syncytial Virus (RSV) Overview
RSV is a common virus causing cold-like symptoms in adults but severe bronchiolitis or pneumonia in infants and elderly. Almost all children catch it by age 2.
No routine vaccine is widely available in Australia yet, though monoclonal antibodies protect high-risk infants.
Influenza (Flu) Explained
Influenza A and B strains cause seasonal outbreaks. Symptoms appear suddenly and can lead to complications like pneumonia.
Annual flu vaccines are updated to match circulating strains.
COVID-19 and Its Variants
SARS-CoV-2 continues evolving, with milder but still significant waves. Boosters reduce severe outcomes.
Long COVID remains a concern for some. Semantically related: SARS-CoV-2, herd immunity.
Symptoms and How to Differentiate Them
Symptoms overlap considerably, making self-diagnosis difficult.
Common Symptoms Across the Viruses
Fever, cough, fatigue, sore throat, runny nose, and body aches occur with all three. Headache and muscle pain are frequent.
Children may show irritability or reduced feeding.
Checklist: Typical Symptom Onset
- Flu: Sudden (hours)
- COVID: 2–14 days after exposure
- RSV: 4–6 days after exposure
Key Differences and Red Flags
Loss of taste or smell points strongly to COVID. Wheezing or breathing difficulty in infants suggests RSV.
High fever with rapid worsening warrants urgent care.
| :Symptom | :Flu | :COVID-19 | :RSV |
| :Fever | :Common, high | :Common | :Common in children |
| :Cough | :Dry or productive | :Dry | :Often wheezy |
| :Fatigue | :Severe | :Severe | :Mild to moderate |
| :Loss of taste/smell | :Rare | :Possible | :Rare |
| :Breathing difficulty | :Possible | :Possible | :Common in infants |
If caring for someone unwell, carers' certificates for family illnesses can support time off work.
Impact on Vulnerable Groups and Communities
Certain groups face greater risks from these viruses.
Risks for Children, Elderly, and Immunocompromised
RSV hospitalises thousands of infants annually. Flu and COVID disproportionately affect those over 65 and immunocompromised.
Co-infection can worsen outcomes. Semantically related: high-risk groups, hospital admissions.
Effects on Healthcare and Daily Life
Increased presentations strain emergency departments. Work and school absences rise.
For illness-related leave, online medical certificates for respiratory illnesses provide convenient documentation.
Prevention and Vaccination Strategies
Vaccination offers the best protection.
Vaccines and Boosters Available in Australia
Flu vaccine is free for children under 5, pregnant women, over 65s, and Aboriginal and Torres Strait Islander people. COVID boosters are recommended for all adults.
RSV prevention includes nirsevimab for high-risk infants.
Checklist: Who Should Get Vaccinated
- Flu: Everyone 6 months and older
- COVID: Boosters if last dose >6 months ago
- High-risk infants: Discuss RSV antibody with GP
Everyday Preventive Measures
Wash hands frequently, cover coughs, stay home when unwell, and improve ventilation.
Masks help in crowded settings.
Visual Suggestion: Infographic showing handwashing, vaccination, and mask icons.
Management and When to Seek Help
Most cases resolve with supportive care.
Home Care Tips
Rest, hydrate, and use paracetamol for fever. Isolate to prevent spread.
Monitor for worsening symptoms.
Role of Telehealth in Respiratory Care
Telehealth allows safe assessment without risking further transmission. Doctors can advise on testing, antivirals, or referral.
Conclusion
The triple respiratory threat in Australia throughout 2025–2026, driven by high levels of flu, COVID-19, and RSV, reminds us to stay vigilant. Vaccination, hygiene, and early care reduce risks significantly.
If you’re concerned about respiratory symptoms or need advice, book a consultation with HootHealth’s AHPRA-registered doctors today.
